Both at the Same Time

Both population-scale and personalized medicine are needed, argue researchers from Brigham and Women's Hospital and Harvard Medical School in the Journal of the American Medical Association this week.

In the past, Harvard's Elliott Antman and his colleagues write that medical studies focused on small groups of patients that they then extrapolated to whole populations. But with better and more data collection, researchers can both study broad populations as well as individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.